paclitaxel has been researched along with Leukemia L 1210 in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (61.54) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhakuni, RS; Johnson, J; Oruganti, RS; Rao, KV | 1 |
Hosoyama, H; Kobayashi, J; Shigemori, H; Sudo, Y; Tsuruo, T; Wang, XX | 1 |
Christen, TD; Fondy, TP; Gadeberg, L; Sansky, M; Trendowski, M; Wong, V; Zoino, JN | 1 |
Hosokawa, Y; Kakinoki, A; Kaneo, Y; Tanaka, T | 1 |
Citardi, MJ; Donehower, RC; Noe, DA; Rowinsky, EK | 1 |
Tritton, TR; Vichi, PJ | 1 |
Conover, CD; Gilbert, CW; Greenwald, RB; Martinez, A; Pendri, A; Xia, J | 1 |
Holm, B; Jensen, PB; Sehested, M | 1 |
Briggs, KE; Cabanes, A; Gokhale, PC; Rahman, A; Treat, JA | 1 |
Feleszko, W; Giermasz, A; Gołab, J; Jakóbisiak, M; Lasek, W; Nowicka, D; Stokłosa, T; Zagozdzon, R | 1 |
Bae, K; Jung, H; Kim, Y; Lee, J; Min, B; Sok, DE | 1 |
Edatsugi, H; Matsuba, Y; Matsunaga, A; Mita, I; Nakanishi, O | 1 |
Assreuy, J; Sampaio de Freitas, M; Santos-Silva, MC | 1 |
13 other study(ies) available for paclitaxel and Leukemia L 1210
Article | Year |
---|---|
Synthesis and evaluation of some 10-mono- and 2',10-diesters of 10-deacetylpaclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Esters; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1995 |
Modulation of multidrug resistance by taxuspine C and other taxoids from Japanese yew.
Topics: Animals; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia L1210; Leukemia P388; Mice; Phenylpropionates; Taxoids; Trees; Tumor Cells, Cultured; Vincristine | 1998 |
Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Death; Cell Growth Processes; Culture Media, Serum-Free; Cytochalasin B; Cytoskeleton; Depsipeptides; Humans; Leukemia; Leukemia L1210; Mice; Microtubules; Paclitaxel; U937 Cells; Ultrasonic Therapy; Ultrasonography; Vincristine | 2015 |
Synthesis and evaluation of water-soluble poly(vinyl alcohol)-paclitaxel conjugate as a macromolecular prodrug.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Survival; Chromatography, High Pressure Liquid; Doxorubicin; Drug Carriers; Hydrogen-Ion Concentration; Injections, Intravenous; Kinetics; Leukemia L1210; Male; Mice; Paclitaxel; Polyvinyl Alcohol; Prodrugs; Sarcoma 180; Solubility; Spectrophotometry, Ultraviolet; Tissue Distribution; Water | 2008 |
Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Administration Schedule; Leukemia L1210; Mice; Paclitaxel; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine | 1993 |
Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
Topics: Amsacrine; Animals; Biological Transport; Brefeldin A; Cell Survival; Cyclopentanes; DNA Damage; DNA Repair; Doxorubicin; Drug Synergism; Endoplasmic Reticulum; Etoposide; Golgi Apparatus; Kinetics; Leukemia L1210; Mice; Microtubules; Nocodazole; Paclitaxel; Temperature; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1993 |
Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Half-Life; Hydrolysis; Lethal Dose 50; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Paclitaxel; Polyethylene Glycols; Prodrugs; Tumor Cells, Cultured | 1996 |
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Central Nervous System Neoplasms; DNA Topoisomerases, Type II; Etoposide; Female; Injections, Intraperitoneal; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Paclitaxel; Razoxane; Structure-Activity Relationship | 1996 |
Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel.
Topics: Animals; Drug Carriers; Female; Half-Life; Leukemia L1210; Liposomes; Male; Metabolic Clearance Rate; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Paclitaxel; Tissue Distribution | 1998 |
Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
Topics: Animals; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Immunotherapy; Interferon-gamma; Interleukin-12; Leukemia L1210; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Paclitaxel; Recombinant Proteins; Survival Analysis; Time Factors; Whole-Body Irradiation | 1998 |
Potentiating effect of obacunone from Dictamnus dasycarpus on cytotoxicity of microtuble inhibitors, vincristine, vinblastine and taxol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzopyrans; Benzoxepins; Drug Screening Assays, Antitumor; Drug Synergism; Leukemia L1210; Limonins; Magnetic Resonance Spectroscopy; Mice; Microtubules; Paclitaxel; Plants, Medicinal; Vinblastine; Vincristine | 2000 |
A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Benzimidazoles; Cell Survival; Cisplatin; Colonic Neoplasms; DNA; Female; Fluorescent Dyes; Humans; Leukemia L1210; Leukemia P388; Macromolecular Substances; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Paclitaxel; Pyrroles; Radiation-Sensitizing Agents | 2000 |
Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cytoskeleton; Drug Synergism; Humans; Leukemia L1210; Leukemia, Lymphoid; Mice; Molsidomine; NF-kappa B; Nitric Oxide; Nitric Oxide Donors; Paclitaxel; Penicillamine; Protein Synthesis Inhibitors; Pyrrolidines; Thiocarbamates; Tumor Cells, Cultured | 2001 |